Cupps Capital Management’s DexCom DXCM Stock Holding History

Cupps Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.69M	Sell	122,736 -156,288	-56%	-$3.48M	1.16%	18
2016 Q2	$5.53M	Buy	279,024 +105,168	+60%	+$1.79M	1.43%	13
2016 Q1	$2.95M	Buy	173,856 +30,072	+21%	+$502K	0.56%	72
2015 Q4	$2.94M	Buy	143,784 +44,060	+44%	+$917K	0.41%	84
2015 Q3	$2.14M	Sell	99,724 -291,264	-74%	-$6.5M	0.28%	96
2015 Q2	$7.82M	Sell	390,988 -364,708	-48%	-$6.41M	0.75%	54
2015 Q1	$11.8M	Sell	755,696 -988,440	-57%	-$14.9M	1.05%	33
2014 Q4	$24M	Sell	1,744,136 -771,988	-31%	-$9.45M	2.15%	7
2014 Q3	$25.2M	Sell	2,516,124 -845,828	-25%	-$8.65M	2.33%	4
2014 Q2	$33.3M	Sell	3,361,952 -650,156	-16%	-$5.76M	2.7%	2
2014 Q1	$41.5M	Sell	4,012,108 -1,480,256	-27%	-$15.3M	3.18%	2
2013 Q4	$48.6M	Sell	5,492,364 -1,033,420	-16%	-$8.18M	3.3%	2
2013 Q3	$46M	Buy	6,525,784 +699,300	+12%	+$4.43M	2.98%	3
2013 Q2	$32.7M	Buy	+5,826,484	New	+$27.9M	2.61%	10

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Cupps Capital Management's DXCM Position: Q3 2016 in Review

Cupps Capital Management reduced its DexCom (DXCM) stake by 56% in Q3 2016, selling an estimated $3.48M and leaving 122,736 shares worth $2.69M. The position accounts for 1.16% of the portfolio, ranked #18.

Cupps Capital Management first reported a position in DXCM in Q2 2013 and has held it in 14 quarters since. The position peaked at $48.6M in Q4 2013. 289 funds tracked by Wall St. Rank hold DXCM as of Q3 2016.

Cupps Capital Management held 122,736 shares of DexCom worth $2.69M as of Q3 2016.
Cupps Capital Management sold 156,288 DexCom shares in Q3 2016, an estimated $3.48M.
DexCom made up 1.16% of Cupps Capital Management's portfolio in Q3 2016, its #18 holding.
Cupps Capital Management first reported a position in DexCom in Q2 2013 and has held it in 14 quarters since.
Cupps Capital Management's DexCom position peaked at $48.6M in Q4 2013.
289 funds tracked by Wall St. Rank held DexCom as of Q3 2016.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.